Newborn drug dosing study uses leftover blood samples

NCT ID NCT04031183

Completed Knowledge-focused Sponsor: Rennes University Hospital Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looked at how the antibiotic metronidazole works in 171 newborns to find the best dose. Researchers used leftover blood or spinal fluid from routine tests, so no extra pokes were needed. The goal was to make sure enough babies get the right amount to fight infection without side effects.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for EMERGENCIES are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Emergencies

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

EMERGENCIES

Contacts and locations

Locations

CH St Brieuc

Saint-Brieuc, France
CH Vannes

Vannes, France
CHU d'Angers

Angers, France
CHU de Brest

Brest, France
CHU de Rennes

Rennes, France
CHU de Tours

Tours, France
Centre Robert Debré

Paris, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.